Aleafia Health Inc (ALEAF)

[FUNMAN]

Lucky, I don't think a buyout is what Aleafia is looking for. I see it as a natural byproduct of a successful UNIFOR deal. That said, I will believe that deal when I see revenues from Insurance companies putting Cannabis on their Formulary lists to reimburse cannabis expenditures.

A certain percentage of union members and their families are current cannabis users. A certain percentage of them have various prescriptions for things cannabis could replace.

As today's Tilray approval announcement points out, cannabis can be prescribed for quite a few common problems:

Tilray medical cannabis products are approved for the treatment of

Spasticity associated with Multiple Sclerosis or spinal cord injuries; nausea, vomiting (resulting from chemotherapy, radiation therapy, and combined HIV medication for hepatitis C); appetite stimulation in the palliative care of patients undergoing oncological treatment or with HIV/AIDS; Tourette syndrome, Epilepsy, and treatment of severe seizure disorders in children; therapeutic-resistant Glaucoma and chronic pain (associated with oncological or nervous system diseases such as neuropathic pain injury caused by nerve damage, phantom limb pain, trigeminal neuralgia, or after herpes zoster).

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161379115

IMO, a rapid rise in patient counts at Aleafia could result in a production squeeze not easily remedied. Buying it wholesale could be a slim gross profit bridge to cultivation expansion.

Aleafia could buy moth-balled cultivation facilities.

Aphria could step forward with an attractive buyout offer. They wouldn't have to spend an extra CAPEX penny to meet demand.

Aleafia's mgmt has to be thinking about it.